Tuesday, September 22, 2020
In a time of universal deceit, telling the truth is a revolutionary act.

F.D.A. Panel Endorses Lilly Blood Thinner

The drug, called prasugrel, could pose the first real challenge to Bristol-Myers Squibb’s near monopoly on blood-thinning drugs.

Share on facebook
Facebook
Share on twitter
Twitter
Share on linkedin
LinkedIn

The drug, called prasugrel, could pose the first real challenge to Bristol-Myers Squibb’s near monopoly on blood-thinning drugs.

%d bloggers like this: